128 related articles for article (PubMed ID: 18088385)
1. CaMKIIT287 and T305 regulate history-dependent increases in alpha agonist-induced vascular tone.
Munevar S; Gangopadhyay SS; Gallant C; Colombo B; Sellke FW; Morgan KG
J Cell Mol Med; 2008; 12(1):219-26. PubMed ID: 18088385
[TBL] [Abstract][Full Text] [Related]
2. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
[TBL] [Abstract][Full Text] [Related]
3. Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta.
Kim I; Je HD; Gallant C; Zhan Q; Riper DV; Badwey JA; Singer HA; Morgan KG
J Physiol; 2000 Jul; 526 Pt 2(Pt 2):367-74. PubMed ID: 10896725
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats.
Daniels LJ; Wallace RS; Nicholson OM; Wilson GA; McDonald FJ; Jones PP; Baldi JC; Lamberts RR; Erickson JR
Cardiovasc Diabetol; 2018 Jun; 17(1):89. PubMed ID: 29903013
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species.
Palomeque J; Rueda OV; Sapia L; Valverde CA; Salas M; Petroff MV; Mattiazzi A
Circ Res; 2009 Dec; 105(12):1204-12. PubMed ID: 19850941
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.
Li H; Li W; Gupta AK; Mohler PJ; Anderson ME; Grumbach IM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H688-98. PubMed ID: 20023119
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of Kv4.2 and Kv4.3 channels by calmodulin-dependent protein kinase II in rat cardiac myocytes.
Colinas O; Gallego M; Setién R; López-López JR; Pérez-García MT; Casis O
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1978-87. PubMed ID: 16648177
[TBL] [Abstract][Full Text] [Related]
8. CaMKII knockdown attenuates H2O2-induced phosphorylation of ERK1/2, PKB/Akt, and IGF-1R in vascular smooth muscle cells.
Bouallegue A; Pandey NR; Srivastava AK
Free Radic Biol Med; 2009 Sep; 47(6):858-66. PubMed ID: 19545622
[TBL] [Abstract][Full Text] [Related]
9. The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca
Wong MH; Samal AB; Lee M; Vlach J; Novikov N; Niedziela-Majka A; Feng JY; Koltun DO; Brendza KM; Kwon HJ; Schultz BE; Sakowicz R; Saad JS; Papalia GA
J Mol Biol; 2019 Mar; 431(7):1440-1459. PubMed ID: 30753871
[TBL] [Abstract][Full Text] [Related]
10. Ca²+/calmodulin-dependent protein kinase II (CaMKII) activity and sinoatrial nodal pacemaker cell energetics.
Yaniv Y; Spurgeon HA; Ziman BD; Lakatta EG
PLoS One; 2013; 8(2):e57079. PubMed ID: 23459256
[TBL] [Abstract][Full Text] [Related]
11. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor.
Vest RS; O'Leary H; Coultrap SJ; Kindy MS; Bayer KU
J Biol Chem; 2010 Jul; 285(27):20675-82. PubMed ID: 20424167
[TBL] [Abstract][Full Text] [Related]
12. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
13. CaMKII "autonomy" is required for initiating but not for maintaining neuronal long-term information storage.
Buard I; Coultrap SJ; Freund RK; Lee YS; Dell'Acqua ML; Silva AJ; Bayer KU
J Neurosci; 2010 Jun; 30(24):8214-20. PubMed ID: 20554872
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg1 promotes glutamate release via a calcium/calmodulin-dependent protein kinase II-dependent signaling pathway.
Liu ZJ; Zhao M; Zhang Y; Xue JF; Chen NH
Brain Res; 2010 May; 1333():1-8. PubMed ID: 20381470
[TBL] [Abstract][Full Text] [Related]
15. Excitotoxic neuroprotection and vulnerability with CaMKII inhibition.
Ashpole NM; Hudmon A
Mol Cell Neurosci; 2011 Apr; 46(4):720-30. PubMed ID: 21316454
[TBL] [Abstract][Full Text] [Related]
16. iNOS regulation by calcium/calmodulin-dependent protein kinase II in vascular smooth muscle.
Jones RJ; Jourd'heuil D; Salerno JC; Smith SM; Singer HA
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2634-42. PubMed ID: 17293490
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of Ca(2+)-activated Cl(-) currents in rabbit arterial and portal vein smooth muscle cells by Ca(2+)-calmodulin-dependent kinase.
Greenwood IA; Ledoux J; Leblanc N
J Physiol; 2001 Jul; 534(Pt. 2):395-408. PubMed ID: 11454959
[TBL] [Abstract][Full Text] [Related]
18. Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.
Oestreich EA; Malik S; Goonasekera SA; Blaxall BC; Kelley GG; Dirksen RT; Smrcka AV
J Biol Chem; 2009 Jan; 284(3):1514-22. PubMed ID: 18957419
[TBL] [Abstract][Full Text] [Related]
19. Modulation of intracellular Ca2+ release and capacitative Ca2+ entry by CaMKII inhibitors in bovine vascular endothelial cells.
Aromolaran AA; Blatter LA
Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1426-36. PubMed ID: 16093279
[TBL] [Abstract][Full Text] [Related]
20. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2.
Terentyev D; Belevych AE; Terentyeva R; Martin MM; Malana GE; Kuhn DE; Abdellatif M; Feldman DS; Elton TS; Györke S
Circ Res; 2009 Feb; 104(4):514-21. PubMed ID: 19131648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
